Matricelf is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions. Its technology enables the production of a complete autologous engineered tissue composed of matrix and cells derived from patients’ own tissues.

Matricelf’s novel regenerative medicine platform aims to cure a range of medical conditions including Spinal Cord Injuries (SCI), Age-related Macular Degeneration (AMD), Parkinson’s Disease, Myocardial Infarction etc.